Genotypic Detection of qnrA and qnrC Genes in Citrobacter koseri Isolated from Patients with Urinary Tract Infection

A Sadeq Al-Ethari1, T Hayder Hasan1, K Abbas Tikki1

  • 1Department of Medical Laboratory Techniques, Faculty of Medical and Health Techniques, University of Alkafeel, Najaf, Iraq.

Insights

This study investigated urinary tract infections (UTIs) caused by Citrobacter koseri (C. koseri), finding it a low-prevalence pathogen. C. koseri exhibited high resistance to common antibiotics but remained susceptible to Imipenem, with the qnrA gene detected in most resistant isolates.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Science

Background:

  • Urinary tract infections (UTIs) are common, primarily caused by bacterial agents.
  • While common pathogens are well-documented, less frequent causes like Citrobacter koseri (C. koseri) require specific investigation.
  • Understanding the prevalence and antimicrobial resistance patterns of C. koseri is crucial for effective UTI management.

Purpose of the Study:

  • To determine the prevalence of C. koseri as a causative agent of UTIs in outpatients.
  • To evaluate the antimicrobial resistance profile of C. koseri isolates against commonly used antibiotics.
  • To investigate the presence of the qnrA and qnrC genes in C. koseri isolates.

Main Methods:

  • Urine samples from 249 outpatients with suspected UTIs were collected and cultured.
  • Bacterial identification and isolation were performed using standard microbiological techniques, including blood agar and MacConkey agar.
  • Antimicrobial susceptibility testing was conducted using eight different antimicrobial agents, and the qnrA and qnrC genes were screened using molecular methods.

Main Results:

  • Citrobacter koseri (C. koseri) was identified as a less common cause of UTI in this cohort.
  • C. koseri isolates demonstrated high resistance rates to Cefotaxime, Ceftriaxone, Ciprofloxacin, Ceftazidime, and Levofloxacin.
  • High susceptibility (100%) was observed for Imipenem, while Gentamicin and Amikacin showed moderate resistance. The qnrA gene was present in 85.71% of isolates, but qnrC was absent.

Conclusions:

  • C. koseri is an infrequent UTI pathogen with significant antimicrobial resistance, particularly to fluoroquinolones and cephalosporins.
  • Imipenem is a highly effective antibiotic against C. koseri, indicating its potential as a treatment option.
  • The high prevalence of the qnrA gene suggests its role in the observed fluoroquinolone resistance in C. koseri UTIs.